CD93 and inflammatory skin disease: Similarly, in inflammatory skin diseases, IL-17D regulates keratinocyte-mediated inflammatory responses through the CD93‒p38 MAPK‒protein kinase B (AKT)-Smad2/3 signaling axis (Ni et al., 2022).